What does it take to be the UK’s next tech unicorn, valued at more than $1 billion?

April 20, 2018 11:07 am Published by Leave your thoughts

Industry experts predict Clinova’s commitment to innovation in healthcare will soon see the healthtech company join this exclusive club.

By helping users with basic healthcare advice, Caidr aims to alleviate pressure on NHS services – saving it money and freeing up resources.

Arsalan Karim wants to help make the world a healthier place. To do this, his healthtech company Clinova, co-founded with Charles Ebubedike, has launched Caidr. The digital healthcare app helps users assess common medical issues – like an ear infection or cold – that can be self-treated. Its aim is to help people distinguish these minor ailments from more serious illnesses to decrease unnecessary visits to the GP. A November 2017 self-care survey estimated 57 million GP appointments and 3.7 million A&E visits each year for self-treatable conditions.

A lack of information is driving people to seek advice from doctors unnecessarily. Caidr is the most recent product for Clinova, which counts O.R.S hydration tablets, Wayk alertness tablets, Repelsect insect repellent patches and Magastic digestive tablets among its innovative, natural products made to fill the gap of unmet medical needs. The market size of these products in the 20 countries Clinova operates in – including the UK, Canada, the US and Thailand – is £14 billion, with this success attributed to their focus on modern healthcare, prevention and natural ingredients, and providing a market leading direct to consumer model.

“As digital technology becomes central to our lives, we are harnessing digital opportunities to improve consumer health,” says Karim.

This innovation has attracted some of the biggest names in healthcare. Clinova’s backers include the former head of sales at P&G, the former head of Novartis US, the former head of over-the-counter products at Reckitt Benckiser, and the former head of consumer healthcare at Asia’s largest healthcare company DKSH. “Seven of the ten biggest consumer healthcare companies are in discussions to license our products or technology,” says John Honey, Chief Strategy Officer of Clinova. “We are at the forefront of changes in the global consumer healthcare marketplace.” Where will those changes lead them next? That’s the billion dollar question.

Featured on Wired:


Categorised in: , , , ,

This post was written by david